APO Research
Talk to an analyst

APO RESEARCH · REPORT

PEPs and Sanction Screening

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global PEPs and Sanction Screening Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchPEPs and Sanction Screening Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal PEPs and Sanction Screening Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal PEPs and Sanction Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PEPs and Sanction Screening Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal PEPs and Sanction Screening Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global PEPs and Sanction Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for PEPs and Sanction Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PEPs and Sanction Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PEPs and Sanction Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the PEPs and Sanction Screening market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the PEPs and Sanction Screening market include IDnow, Jumio, Persona, Entrust, Smile ID, Veriff, Trulioo, GBG Plc and Sumsub, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global PEPs and Sanction Screening market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PEPs and Sanction Screening and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PEPs and Sanction Screening revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global PEPs and Sanction Screening market.

PEPs and Sanction Screening Segment by Company

IDnow

Jumio

Persona

Entrust

Smile ID

Veriff

Trulioo

GBG Plc

Sumsub

Ondato

NameScan

Castellum.AI

Dotfile

RELX (LexisNexis)

Owlin

Dilisense GmbH

Fenergo

Thirdfort

Experian

AU10TIX

PEPs and Sanction Screening Segment by Type

Software

Service

PEPs and Sanction Screening Segment by Application

BFSI

iGaming

Payments

eCommerce

Other

PEPs and Sanction Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global PEPs and Sanction Screening status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the PEPs and Sanction Screening key companies, revenue, market share, and recent developments.

3. To split the PEPs and Sanction Screening breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions PEPs and Sanction Screening market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify PEPs and Sanction Screening significant trends, drivers, influence factors in global and regions.

6. To analyze PEPs and Sanction Screening competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PEPs and Sanction Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PEPs and Sanction Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PEPs and Sanction Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global PEPs and Sanction Screening industry.

Chapter 3: Detailed analysis of PEPs and Sanction Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of PEPs and Sanction Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of PEPs and Sanction Screening in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. PEPs and Sanction Screening Industry Trends Table 2. PEPs and Sanction Screening Industry Drivers Table 3. PEPs and Sanction Screening Industry Opportunities and Challenges Table 4. PEPs and Sanction Screening Industry Restraints Table 5. Global PEPs and Sanction Screening Revenue by Company (US$ Million) & (2021-2026) Table 6. Global PEPs and Sanction Screening Revenue Share by Company (2021-2026) Table 7. Global PEPs and Sanction Screening Company Ranking, (2024-2026) & (US$ Million) Table 8. Global PEPs and Sanction Screening Key Company Manufacturing Base & Headquarters Table 9. Global PEPs and Sanction Screening Company, Product Type & Application Table 10. Global PEPs and Sanction Screening Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global PEPs and Sanction Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Software Table 15. Significant Companies of Service Table 16. Global PEPs and Sanction Screening Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global PEPs and Sanction Screening Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global PEPs and Sanction Screening Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global PEPs and Sanction Screening Sales Value Share by Type (2021-2026) Table 20. Global PEPs and Sanction Screening Sales Value Share by Type (2027-2032) Table 21. Significant Companies of BFSI Table 22. Significant Companies of iGaming Table 23. Significant Companies of Payments Table 24. Significant Companies of eCommerce Table 25. Significant Companies of Other Table 26. Global PEPs and Sanction Screening Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global PEPs and Sanction Screening Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global PEPs and Sanction Screening Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global PEPs and Sanction Screening Sales Value Share by Application (2021-2026) Table 30. Global PEPs and Sanction Screening Sales Value Share by Application (2027-2032) Table 31. Global PEPs and Sanction Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global PEPs and Sanction Screening Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global PEPs and Sanction Screening Sales Value Share by Region (2021-2026) Table 34. Global PEPs and Sanction Screening Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global PEPs and Sanction Screening Sales Value Share by Region (2027-2032) Table 36. Global PEPs and Sanction Screening Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global PEPs and Sanction Screening Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global PEPs and Sanction Screening Sales Value Market Share by Country (2021-2026) Table 39. Global PEPs and Sanction Screening Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global PEPs and Sanction Screening Sales Value Market Share by Country (2027-2032) Table 41. IDnow Company Information Table 42. IDnow Business Overview Table 43. IDnow PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. IDnow PEPs and Sanction Screening Product Portfolio Table 45. IDnow Recent Development Table 46. Jumio Company Information Table 47. Jumio Business Overview Table 48. Jumio PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Jumio PEPs and Sanction Screening Product Portfolio Table 50. Jumio Recent Development Table 51. Persona Company Information Table 52. Persona Business Overview Table 53. Persona PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Persona PEPs and Sanction Screening Product Portfolio Table 55. Persona Recent Development Table 56. Entrust Company Information Table 57. Entrust Business Overview Table 58. Entrust PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Entrust PEPs and Sanction Screening Product Portfolio Table 60. Entrust Recent Development Table 61. Smile ID Company Information Table 62. Smile ID Business Overview Table 63. Smile ID PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Smile ID PEPs and Sanction Screening Product Portfolio Table 65. Smile ID Recent Development Table 66. Veriff Company Information Table 67. Veriff Business Overview Table 68. Veriff PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Veriff PEPs and Sanction Screening Product Portfolio Table 70. Veriff Recent Development Table 71. Trulioo Company Information Table 72. Trulioo Business Overview Table 73. Trulioo PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Trulioo PEPs and Sanction Screening Product Portfolio Table 75. Trulioo Recent Development Table 76. GBG Plc Company Information Table 77. GBG Plc Business Overview Table 78. GBG Plc PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GBG Plc PEPs and Sanction Screening Product Portfolio Table 80. GBG Plc Recent Development Table 81. Sumsub Company Information Table 82. Sumsub Business Overview Table 83. Sumsub PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sumsub PEPs and Sanction Screening Product Portfolio Table 85. Sumsub Recent Development Table 86. Ondato Company Information Table 87. Ondato Business Overview Table 88. Ondato PEPs and Sanction Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Ondato PEPs and Sanction Screening Product Portfolio Table 90. Ondato Recent Development Table 91. NameScan Company Information Table 92. NameScan Business Overview Table 93. NameScan PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. NameScan PEPs and Sanction Screening Product Portfolio Table 95. NameScan Recent Development Table 96. Castellum.AI Company Information Table 97. Castellum.AI Business Overview Table 98. Castellum.AI PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Castellum.AI PEPs and Sanction Screening Product Portfolio Table 100. Castellum.AI Recent Development Table 101. Dotfile Company Information Table 102. Dotfile Business Overview Table 103. Dotfile PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Dotfile PEPs and Sanction Screening Product Portfolio Table 105. Dotfile Recent Development Table 106. RELX (LexisNexis) Company Information Table 107. RELX (LexisNexis) Business Overview Table 108. RELX (LexisNexis) PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. RELX (LexisNexis) PEPs and Sanction Screening Product Portfolio Table 110. RELX (LexisNexis) Recent Development Table 111. Owlin Company Information Table 112. Owlin Business Overview Table 113. Owlin PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Owlin PEPs and Sanction Screening Product Portfolio Table 115. Owlin Recent Development Table 116. Dilisense GmbH Company Information Table 117. Dilisense GmbH Business Overview Table 118. Dilisense GmbH PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Dilisense GmbH PEPs and Sanction Screening Product Portfolio Table 120. Dilisense GmbH Recent Development Table 121. Fenergo Company Information Table 122. Fenergo Business Overview Table 123. Fenergo PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Fenergo PEPs and Sanction Screening Product Portfolio Table 125. Fenergo Recent Development Table 126. Thirdfort Company Information Table 127. Thirdfort Business Overview Table 128. Thirdfort PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Thirdfort PEPs and Sanction Screening Product Portfolio Table 130. Thirdfort Recent Development Table 131. Experian Company Information Table 132. Experian Business Overview Table 133. Experian PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Experian PEPs and Sanction Screening Product Portfolio Table 135. Experian Recent Development Table 136. AU10TIX Company Information Table 137. AU10TIX Business Overview Table 138. AU10TIX PEPs and Sanction Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. AU10TIX PEPs and Sanction Screening Product Portfolio Table 140. AU10TIX Recent Development Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. PEPs and Sanction Screening Product Image Figure 2. Global PEPs and Sanction Screening Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PEPs and Sanction Screening Market Size (2021-2032) & (US$ Million) Figure 4. Global PEPs and Sanction Screening Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Software Image Figure 8. Service Image Figure 9. Global PEPs and Sanction Screening Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global PEPs and Sanction Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global PEPs and Sanction Screening Sales Value Share by Type (2021-2032) Figure 12. BFSI Image Figure 13. iGaming Image Figure 14. Payments Image Figure 15. eCommerce Image Figure 16. Other Image Figure 17. Global PEPs and Sanction Screening Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global PEPs and Sanction Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global PEPs and Sanction Screening Sales Value Share by Application (2021-2032) Figure 20. Global PEPs and Sanction Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global PEPs and Sanction Screening Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America PEPs and Sanction Screening Sales Value (2021-2032) & (US$ Million) Figure 23. North America PEPs and Sanction Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe PEPs and Sanction Screening Sales Value (2021-2032) & (US$ Million) Figure 25. Europe PEPs and Sanction Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific PEPs and Sanction Screening Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific PEPs and Sanction Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America PEPs and Sanction Screening Sales Value (2021-2032) & (US$ Million) Figure 29. South America PEPs and Sanction Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa PEPs and Sanction Screening Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa PEPs and Sanction Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt PEPs and Sanction Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Service
Applications
  • BFSI
  • iGaming
  • Payments
  • eCommerce
  • Other
Companies covered
  • IDnow
  • Jumio
  • Persona
  • Entrust
  • Smile ID
  • Veriff
  • Trulioo
  • GBG Plc
  • Sumsub
  • Ondato
  • NameScan
  • Castellum.AI
  • Dotfile
  • RELX (LexisNexis)
  • Owlin
  • Dilisense GmbH
  • Fenergo
  • Thirdfort
  • Experian
  • AU10TIX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PEPs and Sanction Screening Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PEPs and Sanction Screening Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 PEPs and Sanction Screening Market Dynamics
  1. 2.1 PEPs and Sanction Screening Industry Trends
  2. 2.2 PEPs and Sanction Screening Industry Drivers
  3. 2.3 PEPs and Sanction Screening Industry Opportunities and Challenges
  4. 2.4 PEPs and Sanction Screening Industry Restraints
3 PEPs and Sanction Screening Market by Company
  1. 3.1 Global PEPs and Sanction Screening Company Revenue Ranking in 2025
  2. 3.2 Global PEPs and Sanction Screening Revenue by Company (2021-2026)
  3. 3.3 Global PEPs and Sanction Screening Company Ranking (2024-2026)
  4. 3.4 Global PEPs and Sanction Screening Company Manufacturing Base and Headquarters
  5. 3.5 Global PEPs and Sanction Screening Company Product Type and Application
  6. 3.6 Global PEPs and Sanction Screening Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global PEPs and Sanction Screening Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 PEPs and Sanction Screening Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 PEPs and Sanction Screening Market by Type
  1. 4.1 PEPs and Sanction Screening Type Introduction
  2. 4.1.1 Software
  3. 4.1.2 Service
  4. 4.2 Global PEPs and Sanction Screening Sales Value by Type
  5. 4.2.1 Global PEPs and Sanction Screening Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global PEPs and Sanction Screening Sales Value by Type (2021-2032)
  7. 4.2.3 Global PEPs and Sanction Screening Sales Value Share by Type (2021-2032)
5 PEPs and Sanction Screening Market by Application
  1. 5.1 PEPs and Sanction Screening Application Introduction
  2. 5.1.1 BFSI
  3. 5.1.2 iGaming
  4. 5.1.3 Payments
  5. 5.1.4 eCommerce
  6. 5.1.5 Other
  7. 5.2 Global PEPs and Sanction Screening Sales Value by Application
  8. 5.2.1 Global PEPs and Sanction Screening Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global PEPs and Sanction Screening Sales Value by Application (2021-2032)
  10. 5.2.3 Global PEPs and Sanction Screening Sales Value Share by Application (2021-2032)
6 PEPs and Sanction Screening Regional Value Analysis
  1. 6.1 Global PEPs and Sanction Screening Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PEPs and Sanction Screening Sales Value by Region (2021-2032)
  3. 6.2.1 Global PEPs and Sanction Screening Sales Value by Region: 2021-2026
  4. 6.2.2 Global PEPs and Sanction Screening Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PEPs and Sanction Screening Sales Value (2021-2032)
  7. 6.3.2 North America PEPs and Sanction Screening Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe PEPs and Sanction Screening Sales Value (2021-2032)
  10. 6.4.2 Europe PEPs and Sanction Screening Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific PEPs and Sanction Screening Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific PEPs and Sanction Screening Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America PEPs and Sanction Screening Sales Value (2021-2032)
  16. 6.6.2 South America PEPs and Sanction Screening Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa PEPs and Sanction Screening Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa PEPs and Sanction Screening Sales Value Share by Country, 2025 VS 2032
7 PEPs and Sanction Screening Country-level Value Analysis
  1. 7.1 Global PEPs and Sanction Screening Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global PEPs and Sanction Screening Sales Value by Country (2021-2032)
  3. 7.2.1 Global PEPs and Sanction Screening Sales Value by Country (2021-2026)
  4. 7.2.2 Global PEPs and Sanction Screening Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt PEPs and Sanction Screening Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt PEPs and Sanction Screening Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt PEPs and Sanction Screening Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IDnow
  2. 8.1.1 IDnow Company Information
  3. 8.1.2 IDnow Business Overview
  4. 8.1.3 IDnow PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IDnow PEPs and Sanction Screening Product Portfolio
  6. 8.1.5 IDnow Recent Developments
  7. 8.2 Jumio
  8. 8.2.1 Jumio Company Information
  9. 8.2.2 Jumio Business Overview
  10. 8.2.3 Jumio PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jumio PEPs and Sanction Screening Product Portfolio
  12. 8.2.5 Jumio Recent Developments
  13. 8.3 Persona
  14. 8.3.1 Persona Company Information
  15. 8.3.2 Persona Business Overview
  16. 8.3.3 Persona PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Persona PEPs and Sanction Screening Product Portfolio
  18. 8.3.5 Persona Recent Developments
  19. 8.4 Entrust
  20. 8.4.1 Entrust Company Information
  21. 8.4.2 Entrust Business Overview
  22. 8.4.3 Entrust PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Entrust PEPs and Sanction Screening Product Portfolio
  24. 8.4.5 Entrust Recent Developments
  25. 8.5 Smile ID
  26. 8.5.1 Smile ID Company Information
  27. 8.5.2 Smile ID Business Overview
  28. 8.5.3 Smile ID PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Smile ID PEPs and Sanction Screening Product Portfolio
  30. 8.5.5 Smile ID Recent Developments
  31. 8.6 Veriff
  32. 8.6.1 Veriff Company Information
  33. 8.6.2 Veriff Business Overview
  34. 8.6.3 Veriff PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Veriff PEPs and Sanction Screening Product Portfolio
  36. 8.6.5 Veriff Recent Developments
  37. 8.7 Trulioo
  38. 8.7.1 Trulioo Company Information
  39. 8.7.2 Trulioo Business Overview
  40. 8.7.3 Trulioo PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Trulioo PEPs and Sanction Screening Product Portfolio
  42. 8.7.5 Trulioo Recent Developments
  43. 8.8 GBG Plc
  44. 8.8.1 GBG Plc Company Information
  45. 8.8.2 GBG Plc Business Overview
  46. 8.8.3 GBG Plc PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GBG Plc PEPs and Sanction Screening Product Portfolio
  48. 8.8.5 GBG Plc Recent Developments
  49. 8.9 Sumsub
  50. 8.9.1 Sumsub Company Information
  51. 8.9.2 Sumsub Business Overview
  52. 8.9.3 Sumsub PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sumsub PEPs and Sanction Screening Product Portfolio
  54. 8.9.5 Sumsub Recent Developments
  55. 8.10 Ondato
  56. 8.10.1 Ondato Company Information
  57. 8.10.2 Ondato Business Overview
  58. 8.10.3 Ondato PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ondato PEPs and Sanction Screening Product Portfolio
  60. 8.10.5 Ondato Recent Developments
  61. 8.11 NameScan
  62. 8.11.1 NameScan Company Information
  63. 8.11.2 NameScan Business Overview
  64. 8.11.3 NameScan PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NameScan PEPs and Sanction Screening Product Portfolio
  66. 8.11.5 NameScan Recent Developments
  67. 8.12 Castellum.AI
  68. 8.12.1 Castellum.AI Company Information
  69. 8.12.2 Castellum.AI Business Overview
  70. 8.12.3 Castellum.AI PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Castellum.AI PEPs and Sanction Screening Product Portfolio
  72. 8.12.5 Castellum.AI Recent Developments
  73. 8.13 Dotfile
  74. 8.13.1 Dotfile Company Information
  75. 8.13.2 Dotfile Business Overview
  76. 8.13.3 Dotfile PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dotfile PEPs and Sanction Screening Product Portfolio
  78. 8.13.5 Dotfile Recent Developments
  79. 8.14 RELX (LexisNexis)
  80. 8.14.1 RELX (LexisNexis) Company Information
  81. 8.14.2 RELX (LexisNexis) Business Overview
  82. 8.14.3 RELX (LexisNexis) PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  83. 8.14.4 RELX (LexisNexis) PEPs and Sanction Screening Product Portfolio
  84. 8.14.5 RELX (LexisNexis) Recent Developments
  85. 8.15 Owlin
  86. 8.15.1 Owlin Company Information
  87. 8.15.2 Owlin Business Overview
  88. 8.15.3 Owlin PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Owlin PEPs and Sanction Screening Product Portfolio
  90. 8.15.5 Owlin Recent Developments
  91. 8.16 Dilisense GmbH
  92. 8.16.1 Dilisense GmbH Company Information
  93. 8.16.2 Dilisense GmbH Business Overview
  94. 8.16.3 Dilisense GmbH PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Dilisense GmbH PEPs and Sanction Screening Product Portfolio
  96. 8.16.5 Dilisense GmbH Recent Developments
  97. 8.17 Fenergo
  98. 8.17.1 Fenergo Company Information
  99. 8.17.2 Fenergo Business Overview
  100. 8.17.3 Fenergo PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Fenergo PEPs and Sanction Screening Product Portfolio
  102. 8.17.5 Fenergo Recent Developments
  103. 8.18 Thirdfort
  104. 8.18.1 Thirdfort Company Information
  105. 8.18.2 Thirdfort Business Overview
  106. 8.18.3 Thirdfort PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Thirdfort PEPs and Sanction Screening Product Portfolio
  108. 8.18.5 Thirdfort Recent Developments
  109. 8.19 Experian
  110. 8.19.1 Experian Company Information
  111. 8.19.2 Experian Business Overview
  112. 8.19.3 Experian PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Experian PEPs and Sanction Screening Product Portfolio
  114. 8.19.5 Experian Recent Developments
  115. 8.20 AU10TIX
  116. 8.20.1 AU10TIX Company Information
  117. 8.20.2 AU10TIX Business Overview
  118. 8.20.3 AU10TIX PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  119. 8.20.4 AU10TIX PEPs and Sanction Screening Product Portfolio
  120. 8.20.5 AU10TIX Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst